1 asset in Prurigo Nodularis
Therapeutic assets addressing Prurigo Nodularis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Povorcitinib Prurigo Nodularis | Incyte Corporation | P3 | B (60) |
Therapeutic assets addressing Prurigo Nodularis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Povorcitinib Prurigo Nodularis | Incyte Corporation | P3 | B (60) |